Skip to content

Financial Calendar

28 April 2023: Annual Report for 2022

22 May 2023: Annual General Meeting

23 August 2023: Half Year / HY1 Report 2023 


May 19:  Assoc. Prof. Marco Bortolato (Dept Pharmacology & Toxicology, University of Utah) presents Asarina Pharma’s Phase IIa results at  TicCon – the Virtual National Conference of the Tourette Association of America, at 9.30 PM CET. His presentation is titled: ‘Putative  novel pharmacological treatments for tic disorders’. Register here:

June 5-8: CEO Peter Nordkild and Business Development Officer Otto Skolling attend BIO 2023, Boston International Convention Center, Boston Mass. US. Register here:

June 7-9: Consultant Neurologist Dr. Heidi Biernat presents Asarina’s Phase IIa data at EESTS, the 15th European Conference on Tourette Syndrome and Tic Disorders in Brussels Belgium. Register for the event here:

Follow us on our social media channels as we post on each event.